Pharmafile Logo
Pharmafocus logo
Advanced Search
astrazeneca_sign_sky

Rare nerve disorder listed as possible side effect of AZ’s COVID vaccine in EU

September 9, 2021

An extremely rare nerve-damaging disorder, Guillain-Barré syndrome (GBS), has been listed by EU regulators as a possible side effect from …

News

Trials of former Theranos CEO Elizabeth Holmes are underway

September 8, 2021
Medical Communications, Research and Development

The highly anticipated trials of Elizabeth Holmes, founder and former CEO of the now-defunct Theranos, have commenced. Prosecutors are to …

News

J&J’s prostate cancer drug recommended by NICE

September 8, 2021
Research and Development

J&J have announced NICE are recommending apalutamide for treating prostate cancer following new draft guidance by the body. This is …

News
clinical_trials_2

Amneal’s IPX-203 shows promising results for motor fluctuations in Parkinson’s disease

September 8, 2021
Research and Development

Amneal Pharmaceuticals has recently announced that its product IPX-203 (carbidopa + levodopa, (CD/LD)) achieved key primary and secondary endpoints in …

News
cdc-un8tv9pw2ik-unsplash_1

COVID booster vaccines to get green light in “next few days”, according to health secretary

September 8, 2021
Research and Development

Coronavirus booster jabs are expected to be approved in “the next few days”, the UK Health Secretary, Sajid David, has …

News

STI rates remain at concerning level despite 2020 fall

September 8, 2021
Research and Development

New data from Public Health England (PHE) reveal that despite diagnoses of sexually transmitted infections (STIs) decreasing in 2020 by …

News
sanofi_hq__boetie_hall_web

Sanofi acquires Kadmon in $1.9 billion deal

September 8, 2021
Research and Development

Sanofi has announced that is has entered into a definitive merger agreement with Kadmon Holdings adding Rezurock (belumosudil) to its …

News

Wider use of SGLT2 inhibitors for CVD recommended by NICE

September 7, 2021
Manufacturing and Production, Medical Communications

NICE has updated its guidelines on the management of type 2 diabetes, recommending wider use of SGLT2 inhibitors in those …

News

FDA halts BioMarin’s PKU gene therapy trial

September 7, 2021
Manufacturing and Production, Medical Communications, Research and Development

BioMarin Pharma has announced that the FDA has slapped a clinical hold on its Phase 1/2 trial of its candidate …

News
nhs_sign

NHS to receive additional £5.4 billion for COVID-19 response

September 7, 2021
Manufacturing and Production

The NHS will receive an extra £5.4 billion over the next six months to support its response to COVID-19 and …

News

Vaginal ring could help prevent HIV infection in women

September 7, 2021
Manufacturing and Production, Research and Development

Researchers from the Kenya Medical Research Institute (KEMRI) are exploring the use of an intra vaginal ring containing anti-HIV medication …

News

“Highly effective” rheumatoid arthritis treatment possible after breakthrough

September 7, 2021
Manufacturing and Production

A “highly effective” treatment for rheumatoid arthritis could be made available in several years after scientists have uncovered a new …

News

Sinovac booster jab reverses antibody drop from Delta variant, study finds

September 6, 2021
Medical Communications, Research and Development, Sales and Marketing

Researchers have found that a booster shot of Sinovac’s COVID-19 vaccine reverses a decline in antibody activities against the Delta …

News

Israel to present COVID booster-shot data to FDA

September 6, 2021
Sales and Marketing

This month Israel will present COVID booster-shot data to the FDA, which is weighing White House plans to begin a …

News

COVID vaccine passports to start in England this month

September 6, 2021
Medical Communications, Sales and Marketing

The Vaccine Minister, Nadhim Zahawi, has confirmed that vaccine passports will be required in nightclubs and other indoor venues at …

News
nice_new_london_office_internal_2_88

Bimekizumab receives first positive health technology assessment worldwide

September 6, 2021
Sales and Marketing

NICE has published its final Technology Appraisal Guidance (TAG) recommending UCB’s BIMZELX (bimekizumab) as a treatment option for adults with …

News

Newron begins first potentially pivotal schizophrenia study

September 6, 2021
Sales and Marketing

Newron has initiated Study 008A, the first potentially pivotal study with evenamide in patients with schizophrenia.Study 008A, a four-week, randomised, …

News

WHO: Number of dementia sufferers to rise 40% to 78 million by 2030

September 3, 2021
Medical Communications

A new report from the WHO has predicted the number of people suffering from dementia is set to rise by …

News

NICE approves secukinumab for young people with severe plaque psoriasis

September 3, 2021
Medical Communications

NICE has approved secukinumab (Cosentyx) as an option for treating moderate to severe plaque psoriasis in people aged six to …

News

Novartis halts kidney transplant drug trial

September 3, 2021
Medical Communications

Novartis has announced that trials investigating CFZ533 (iscalimab) in kidney transplant patients has been halted after interim data show it …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025